Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3077754 | 0.84 | MAPK1 (0.33) | CA2CA1CYP3A4HTTMAPK1 | |
| SCHEMBL19610444 | 0.84 | MAPK1 (0.33) | CA2CA1CYP3A4HTTMAPK1 | |
| SCHEMBL17744958 | 0.81 | THRB (0.37) | CA2CA1CYP3A4HTTMAPK1 | |
| SCHEMBL3082562 | 0.81 | THRB (0.37) | CA2CA1CYP3A4HTTMAPK1 | |
| SCHEMBL3094990 | 0.79 | THRB (0.33) | CYP3A4MAPK1 | |
| SCHEMBL2672671 | 0.77 | LMNA (0.38) | LMNAHSD17B10TSHRCYP3A4NFKB1 | |
| SCHEMBL3081531 | 0.77 | ALDH1A1 (0.36) | LMNAHSD17B10CA2CA1TSHR | |
| SCHEMBL7980194 | 0.77 | — | — | |
| SCHEMBL1141776 | 0.77 | — | — | |
| SCHEMBL2140940 | 0.76 | CTSS (0.34) | LMNACA2CA1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8283095-B2 | Thiourethane compound and photosensitive resin composition | SHOWA DENKO K.K. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-20100233596-A1 | THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | SHOWA DENKO K.K. (JP) | 2010-09-16 | — | — | US | disclosed |
| EP-2055726-A1 | THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Showa Denko K.K. (JP) | 2009-05-06 | — | — | EP | disclosed |
| US-20050265950-A1 | Cross-linked cationic copolymers comprising regulators, and use therof in cosmetic preparations for hair | BASF AKTIENGESELLSCHAFT (DE) | 2005-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100233596-A1 | THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | RCOR3, CBR3, TAS2R3 | LMNA 4454/4885HSD17B10 1796/4885CA2 1942/4885 |
| US-20050265950-A1 | Cross-linked cationic copolymers comprising regulators, and use therof in cosmetic preparations for hair | ETF1, MTHFD2, TWF2 | LMNA 1756/4885HSD17B10 1846/4885CA2 2627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.